U.S. RESEARCH ROUNDUP-Bright Minds Biosciences, Marvell Technology, Oracle Corporation
U.S. RESEARCH ROUNDUP-Bright Minds Biosciences, Marvell Technology, Oracle Corporation Nov 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Bright Minds Biosciences, Marvell Technology and Oracle Corporation on Tuesday.
HIGHLIGHTS
* Bright Minds Biosciences Inc. DRUG.N: BTIG cuts target price to $37 from $147 |
* Marvell Technology, Inc. MRVL.O: BofA Global Research cuts to neutral from buy |
* Once Upon a Farm Pbc OFRM.N: BofA Global Research cuts to underperform from buy |
* Oracle Corporation ORCL.N: Stephens raises to overweight from equal weight |
* Tempus AI, Inc. TEM.O: Jefferies raises to hold from underperform |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* ACI Worldwide, Inc. ACIW.O: D.A. Davidson raises target price to $72 from $66 |
* Advanced Energy Industries, Inc. AEIS.O: TD Cowen cuts target price to $275 from $370 |
* Aehr Test Systems AEHR.O: Jefferies cuts target price to $140 from $175 |
* Alliancebernstein Holding LP AB.N: BofA Global Research cuts PT to $34 from $35 |
* Alphatec Holdings, Inc. ATEC.O: Stephens cuts target price to $9 from $15 |
* Ameriprise Financial Inc AMP.N: BofA Global Research raises PT to $447 from $445 |
* Appian Corp APPN.O: TD Cowen raises target price to $50 from $30 |
* Apple Inc. AAPL.O: JP Morgan cuts target price to $355 from $360 |
* Apple Inc. AAPL.O: Morgan Stanley cuts target price to $350 from $355 |
* Apple Inc. AAPL.O: TD Cowen cuts target price to $390 from $400 |
* Ares Management Corporation ARES.N: BofA Global Research raises PT to $164 from $156 |
* Arthur J. Gallagher & Co. AJG.N: Jefferies raises target price to $319 from $295 |
* Avidbank Holdings Inc AVBH.O: Stephens raises target price to $40 from $37 |
* Axsome Therapeutics, Inc. AXSM.O: Baird cuts target price to $220 from $246 |
* Axsome Therapeutics, Inc. AXSM.O: BofA Global Research cuts PT to $264 from $276 |
* Axsome Therapeutics, Inc. AXSM.O: Jefferies cuts target price to $305 from $380 |
* Axsome Therapeutics, Inc. AXSM.O: Leerink Partners cuts target price to $225 from $245 |
* Axsome Therapeutics, Inc. AXSM.O: Morgan Stanley raises target price to $249 from $247 |
* Axsome Therapeutics, Inc. AXSM.O: Piper Sandler cuts target price to $235 from $238 |
* Bright Minds Biosciences Inc. DRUG.N: Baird cuts target price to $107 from $126 |
* Bright Minds Biosciences Inc. DRUG.N: BTIG cuts target price to $37 from $147 |
* Bright Minds Biosciences Inc. DRUG.N: Piper Sandler cuts target price to $115 from $220 |
* Builders Firstsource Inc BLDR.N: Jefferies raises target price to $68 from $57 |
* Carlyle Group Inc CG.O: JP Morgan raises target price to $64 from $62 |
* CBOE Global Markets, Inc. CBOE.Z: BofA Global Research raises PT to $350 from $329 |
* Cheniere Energy, Inc. LNG.N: TD Cowen raises target price to $352 from $325 |
* Choice Hotels International, Inc. CHH.N: HSBC raises target price to $115 from $105 |
* Church & Dwight Co Inc CHD.N: TD Cowen raises target price to $115 from $97 |
* Cipher Digital Inc CIFR.O: JP Morgan cuts target price to $18 from $22 |
* Circle Internet Group, Inc CRCL.N: JP Morgan raises target price to $110 from $105 |
* Clorox CLX.N: JP Morgan raises target price to $86 from $83 |
* Cohen & Steers Inc CNS.N: BofA Global Research cuts price objective to $46 from $53 |
* Coinbase Global, Inc. COIN.O: BofA Global Research cuts PT to $177 from $203 |
* Coinbase Global, Inc. COIN.O: KBW cuts target price to $221 from $237 |
* Crowdstrike CRWD.O: Deutsche Bank raises to buy from hold; raises PT to $300 from $240 |
* Diamondback Energy, Inc. FANG.O: Gerdes Energy Research cuts target price by $1 to $244 |
* Emerson EMR.N: Morgan Stanley cuts target price to $140 from $145 |
* Estée Lauder EL.N: JP Morgan raises target price to $120 from $115 |
* Estée Lauder EL.N: TD Cowen raises target price to $115 from $100 |
* Everquote, Inc. EVER.O: JP Morgan raises target price to $30 from $29 |
* Exxon Mobil XOM.N: Gerdes Energy Research raises target price by $1 to $162 |
* Fox Corp FOXA.O: JP Morgan raises target price to $83 from $82 |
* Halozyme Therapeutics, Inc. HALO.O: JP Morgan raises target price to $79 from $78 |
* Hii HII.N: JP Morgan raises target price to $375 from $370 |
* Hinge Health, Inc. HNGE.N: Canaccord Genuity raises target price to $134 from $105 |
* Hippo Holdings Inc. HIPO.N: KBW raises target price to $37 from $35 |
* Ichor Holdings, Ltd. ICHR.O: TD Cowen cuts target price to $55 from $100 |
* Inovio Pharmaceuticals Inc INO.O: Piper Sandler raises target price to $8 from $4 |
* Inspire Medical Systems, Inc. INSP.N: Jefferies raises target price to $60 from $55 |
* Inspire Medical Systems, Inc. INSP.N: JP Morgan raises target price to $65 from $60 |
* Inspire Medical Systems, Inc. INSP.N: Piper Sandler raises target price to $70 from $60 |
* Intercontinental Exchange, Inc. ICE.N: BofA Global Research raises PT to $245 from $243 |
* Invesco Ltd IVZ.N: BofA Global Research raises price objective to $37 from $34 |
* Jazz Pharmaceuticals Plc JAZZ.O: JP Morgan raises target price to $310 from $300 |
* Jazz Pharmaceuticals Plc JAZZ.O: RBC raises target price to $305 from $296 |
* Jazz Pharmaceuticals Plc JAZZ.O: Truist Securities raises target price to $291 from $286 |
* KKR Real Estate Finance Trust Inc KREF.N: KBW cuts target price to $5.5 from $6.5 |
* Krystal Biotech, Inc. KRYS.O: BofA Global Research cuts PT to $390 from $400 |
* Krystal Biotech, Inc. KRYS.O: Citigroup cuts target price to $412 from $416 |
* Krystal Biotech, Inc. KRYS.O: RBC cuts target price to $375 from $400 |
* Krystal Biotech, Inc. KRYS.O: TD Cowen cuts target price to $380 from $403 |
* L3Harris Technologies, Inc. LHX.N: BofA Global Research raises PT to $375 from $325 |
* Lumentum Holdings Inc. LITE.O: TD Cowen cuts target price to $685 from $820 |
* Manpowergroup Inc. MAN.N: Exane BNP Paribas cuts target price to $52.5 from $56 |
* Manpowergroup Inc. MAN.N: Exane BNP Paribas cuts to neutral from outperform |
* Marriott MAR.O: HSBC raises target price to $458 from $417 |
* Marriott MAR.O: Jefferies raises target price to $478 from $429 |
* Marriott MAR.O: JP Morgan raises target price to $423 from $406 |
* Marriott MAR.O: Macquarie raises target price to $401 from $372 |
* Marvell Technology, Inc. MRVL.O: BofA Global Research cuts PT to $225 from $400 |
* Marvell Technology, Inc. MRVL.O: BofA Global Research cuts to neutral from buy |
* Marvell Technology, Inc. MRVL.O: Melius Research cuts target price to $250 from $300 |
* Marvell Technology, Inc. MRVL.O: RBC cuts target price to $250 from $425 |
* Marvell Technology, Inc. MRVL.O: TD Cowen cuts target price to $175 from $350 |
* Marvell Technology, Inc. MRVL.O: TD Cowen cuts to hold from buy |
* Match Group MTCH.O: Jefferies cuts target price to $42 from $43 |
* Mohawk Industries, Inc. MHK.N: Jefferies raises target price to $145 from $132 |
* Napco Security Technologies, Inc. NSSC.O: D.A. Davidson cuts PT to $45 from $52 |
* Napco Security Technologies, Inc. NSSC.O: Needham cuts target price to $43 from $49 |
* Nasdaq Inc NDAQ.O: BofA Global Research raises price objective to $135 from $133 |
* Neurocrine Biosciences, Inc. NBIX.O: Canaccord Genuity raises PT to $220 from $210 |
* Neurocrine Biosciences, Inc. NBIX.O: Piper Sandler raises target price to $215 from $210 |
* Neurocrine Biosciences, Inc. NBIX.O: RBC raises target price to $190 from $187 |
* NiSource NI.N: HSBC raises target price to $51.5 from $49.5 |
* Nov Inc. NOV.N: zephirin Group raises price objective by $3 to $20 |
* Nuscale Power Corp SMR.N: Wedbush initiates coverage with target price $5 |
* Nuscale Power Corp SMR.N: Wedbush initiates coverage with underperform rating |
* Once Upon a Farm Pbc OFRM.N: BofA Global Research cuts price objective to $10 from $21 |
* Once Upon a Farm Pbc OFRM.N: BofA Global Research cuts to underperform from buy |
* Once Upon a Farm Pbc OFRM.N: JP Morgan cuts target price to $13 from $26 |
* Opendoor Technologies Inc. OPEN.O: KBW cuts target price to $1.75 from $2.65 |
* Oracle Corporation ORCL.N: Stephens raises target price to $213 from $185 |
* Oracle Corporation ORCL.N: Stephens raises to overweight from equal weight |
* Orange County Bancorp Inc OBT.O: Stephens raises target price to $45 from $42 |
* Palantir Technologies Inc. PLTR.O: Morgan Stanley raises target price to $233 from $205 |
* Palantir Technologies Inc. PLTR.O: Piper Sandler raises target price to $235 from $231 |
* Palantir Technologies Inc. PLTR.O: RBC raises target price to $130 from $90 |
* Pcb Bancorp PCB.O: Piper Sandler raises target price to $33 from $31 |
* Piper Sandler PIPR.N: BofA Global Research cuts price objective to $69 from $75 |
* Primis Financial Corp FRST.O: KBW cuts target price to $17 from $18 |
* Principal Financial Group Inc PFG.O: JP Morgan cuts target price to $105 from $106 |
* Robinhood Markets, Inc. HOOD.O: BofA Global Research cuts PT to $151 from $156 |
* Ryan Specialty Holdings, Inc. RYAN.N: JP Morgan cuts target price to $44 from $45 |
* SBA Communications Corp SBAC.O: JP Morgan cuts target price to $200 from $220 |
* SBA Communications Corp SBAC.O: TD Cowen raises target price to $239 from $229 |
* Sierra Bancorp BSRR.O: KBW raises target price to $44 from $42 |
* Sirius XM Holdings Inc. SIRI.O: JP Morgan cuts target price to $32 from $34 |
* Stepstone Group Inc. STEP.O: JP Morgan cuts target price to $72 from $73 |
* Syndax Pharmaceuticals, Inc. SNDX.O: Jefferies cuts target price to $17 from $35 |
* T. Rowe price Group, Inc. TROW.O: BofA Global Research raises PT to $93 from $90 |
* Tempus AI, Inc. TEM.O: BofA Global Research raises price objective to $90 from $75 |
* Tempus AI, Inc. TEM.O: BTIG raises target price to $100 from $80 |
* Tempus AI, Inc. TEM.O: Jefferies raises target price to $70 from $35 |
* Tempus AI, Inc. TEM.O: Jefferies raises to hold from underperform |
* Tempus AI, Inc. TEM.O: JP Morgan raises target price to $80 from $70 |
* Tempus AI, Inc. TEM.O: Needham raises target price to $89 from $75 |
* Textron Inc TXT.N: BofA Global Research raises price objective to $100 from $95 |
* The Ensign Group, Inc. ENSG.O: RBC raises target price to $239 from $228 |
* The Progressive Corporation PGR.N: Piper Sandler raises target price to $261 from $238 |
* Third Coast Bancshares Inc TCBX.N: KBW cuts target price to $46 from $48 |
* Townebank TOWN.O: KBW raises target price to $39 from $38 |
* TPG Inc TPG.O: BofA Global Research raises price objective to $65 from $58 |
* Tradeweb Markets Inc TW.O: BofA Global Research raises price objective to $186 from $182 |
* V2X, Inc. VVX.N: RBC raises target price to $88 from $81 |
* Verra Mobility Corporation VRRM.O: JP Morgan cuts to underweight from neutral |
* Vertex Pharmaceuticals Incorporated VRTX.O: JP Morgan raises PT to $570 from $560 |
* Vertex Pharmaceuticals Incorporated VRTX.O: RBC raises target price to $600 from $576 |
* Vertex Pharmaceuticals Incorporated VRTX.O: Scotiabank raises PT to $660 from $558 |
* Vertex Pharmaceuticals Incorporated VRTX.O: TD Cowen raises target price to $575 from $550 |
* Vulcan Materials Co VMC.N: Jefferies raises target price to $335 from $320 |
* Walker & Dunlop Inc WD.N: KBW cuts target price to $43 from $45 |
* Waystar Holding Corp. WAY.O: Canaccord Genuity raises target price to $34 from $33 |
* Waystar Holding Corp. WAY.O: Raymond James raises target price to $35 from $32 |
* Waystar Holding Corp. WAY.O: TD Cowen cuts target price to $39 from $42 |
* Xcel Energy XEL.O: HSBC raises target price to $96.5 from $89 |
* Zillow Group, Inc. ZG.O: RBC cuts target price to $45 from $55 |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
Recent news on Alphatec Holdings
See all newsU.S. RESEARCH ROUNDUP-Bright Minds Biosciences, Marvell Technology, Oracle Corporation
Alphatec Holdings, Inc. reports results for the quarter ended September 30 - Earnings Summary
Alphatec Q3 revenue misses expectations on lower biologics attachment
Brief: Alphatec Q3 Basic EPS USD -0.03
Alphatec Holdings, Inc. expected to post earnings of 9 cents a share - Earnings Preview